Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Seishin Shinkeigaku Zasshi ; 107(4): 323-40, 2005.
Artigo em Japonês | MEDLINE | ID: mdl-15920944

RESUMO

UNLABELLED: In Japan, relatively little attention has been paid to atypical depression, which is defined as the presence of mood reactivity and two of four associated features: hyperphagia, hypersomnia, leaden paralysis, rejection sensitivity. The present study was undertaken to obtain detailed clinical information from patients with a diagnosis of atypical depression. We assessed clinical characteristics of each atypical feature, comorbidity of other psychiatric disorders, presence of a stressful life event, and underlying psychological stress in 39 psychiatric outpatients. We also examined the relationship of interpersonal sensitivity to each atypical feature. RESULTS AND DISCUSSION: Mean age of onset was 22 +/- 6, 74% were female, 20 patients (51%) had comorbid social phobia. Thirty (77%) had hyperphagia and 25 of these were women. Twenty (74%) had hypersomnia. Only seven patients reported daytime sleepiness and others (13) reported difficulty in staying awake due to lack of energy. Nineteen (49%) had leaden paralysis. Thirty-two patients (82%) had rejection sensitivity and this symptom correlated with scores of FNE (fears of negative evaluation), LSAS (Liebowits social anxiety scale) and Brief social phobia scale (BSPA). Seven patients reported disappointment in love as a stressful life event preceding the depressive episode. In patients with comorbid social phobia, loss of confidence due to hypersensitivity to rejection or criticism seemed to be the most important factor as a chronic psychologica stress. Seven patients met criteria for bipolar disorder and five out of seven had comorbid generalized social phobia. The clinical and theoretical implications of these findings were discussed.


Assuntos
Depressão/psicologia , Adulto , Ansiedade , Transtorno Bipolar/complicações , Transtorno Bipolar/psicologia , Depressão/complicações , Distúrbios do Sono por Sonolência Excessiva/complicações , Distúrbios do Sono por Sonolência Excessiva/psicologia , Medo , Feminino , Humanos , Hiperfagia/complicações , Hiperfagia/psicologia , Masculino , Transtornos Fóbicos/complicações , Transtornos Fóbicos/psicologia , Rejeição em Psicologia , Estresse Psicológico
2.
Hippocampus ; 14(2): 143-7, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15098719

RESUMO

This study examines the activity of hippocampal CA, pyramidal neurons during conditioned fear stress (CFS)-induced freezing behavior in unanesthetized, unrestrained rats. The firing frequency of hippocampal CA1 pyramidal neurons was significantly decreased when conditioned rats exhibited freezing behavior. Firing frequency returned to the baseline after freezing behavior disappeared. The selective 5-hydroxytryptamine (5-HT)1A antagonists, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide (WAY-100635), and N-tert-butyl-3-[4-(2-methoxyphenyl)piperazine-1-yl]-2-phenylpropamide (WAY-100135) and 5-HT depletion with parachlorophenylalanine (PCPA) completely abolished the decrease in firing frequency during CFS-induced freezing behavior. These results suggested that endogenous 5-HT inhibited the firing activity of hippocampal CA1 pyramidal neurons during CFS-induced freezing behavior mainly through stimulating 5-HT1A receptors.


Assuntos
Condicionamento Psicológico/fisiologia , Medo/fisiologia , Hipocampo/citologia , Hipocampo/fisiologia , Células Piramidais/fisiologia , Receptor 5-HT1A de Serotonina/fisiologia , Serotonina/fisiologia , Estresse Psicológico/fisiopatologia , Animais , Condicionamento Psicológico/efeitos dos fármacos , Eletrofisiologia , Fenclonina/farmacologia , Hipocampo/efeitos dos fármacos , Masculino , Microdiálise , Piperazinas/farmacologia , Células Piramidais/efeitos dos fármacos , Piridinas/farmacologia , Ratos , Ratos Wistar , Receptor 5-HT1A de Serotonina/efeitos dos fármacos , Serotoninérgicos/farmacologia , Antagonistas da Serotonina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA